PROGENE - National Study on Prostate Cancer
Head :
Cussenot Olivier, CEREPP
Last update : 07/15/2014 | Version : 1 | ID : 60134
| General | |
| Identification | |
| Detailed name | National Study on Prostate Cancer |
| Sign or acronym | PROGENE |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL: 27/06/2001 |
| General Aspects | |
| Medical area |
Cancer research |
| Health determinants |
Genetic Social and psychosocial factors |
| Others (details) | Prostate cancer |
| Keywords | anatomopathological, data, weight, height, Health episodes, clinical, family history |
| Scientific investigator(s) (Contact) | |
| Name of the director | Cussenot |
| Surname | Olivier |
| Address | 75020 PARIS |
| Phone | + 33 (0)1 56 01 64 95 |
| olivier.cussenot@tnn.aphp.fr | |
| Unit | CEREPP |
| Organization | APHP |
| Collaborations | |
| Funding | |
| Funding status |
Mixed |
| Details | AP-HP CEREPP |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | CEREPP |
| Organisation status |
Private |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Inclusion method: Prospective Other bodies active in creating this cohort: CHU, CHG, INDEPENDENT PHYSICIANS, CNAM |
| Database objective | |
| Main objective | General objective: To initiate a collection of informative families with at least one member with prostate cancer and apparently health subjects. Secondary objectives: - To identify genes for predisposition and susceptibility to prostate cancer - To identify genetic markers associated with recurrence after treatment - To develop a genetic screening test for these pathologies |
| Inclusion criteria | Men with histologically verified prostate cancer Healthy subjects with PSA levels below 4 ng/ml |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
| Population covered |
Sick population |
| Gender |
Male |
| Geography area |
National |
| Detail of the geography area | France |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 06/2001 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 5965 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data Biological data |
| Clinical data (detail) |
Direct physical measures Medical registration |
| Declarative data (detail) |
Paper self-questionnaire |
| Biological data (detail) | Type of samples taken: Blood and/or saliva and/or urine |
| Presence of a biobank |
Yes |
| Contents of biobank |
Serum DNA |
| Details of biobank content | Serum bank, DNA bank |
| Health parameters studied |
Health event/morbidity Health event/mortality |
| Procedures | |
| Data collection method | Self-administered questionnaire: Entry from a paper questionnaire (Manual input) Clinical examination: Handwritten (Manual input) Biological Analysis: Handwritten (Manual input) |
| Participant monitoring |
Yes |
| Details on monitoring of participants | (Indefinite duration) |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Data may be used by academic teams. Access based on contract collaboration. Data may not be used by industrial teams |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
